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Abstract: Synthesis of natural products via their postulated or established biosynthetic intermediates (‘biomi-
metic synthesis’ or ‘bio-inspired synthesis’) has the power to identify both yet undiscovered intermediates
and undiscovered mechanistic pathways for their formation. In this account, we report on our recent studies
on unusual hypotheses for biosynthetic transformations, such as a late-stage aldol reaction (periconianone A),
benzilic acid rearrangement (taiwaniaquinone H), a redox-neutral light-driven C–H activation (taiwaniaquinol A
and cyclocoulterone), a hetero Diels-Alder reaction (obtusinones), aziridinium chemistry (Securinega alkaloids),
and a [3+2] nitrone olefin cycloaddition (virosaine A). All these studies provided evidence on the molecular level
for the feasibility of these transformations, and suggest that further studies investigating the relevance of these
hypotheses in biological systems are warranted.
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1. Introduction
The structural complexity of natural
products has fascinated chemists for cen-
turies and has challenged them to ratio-
nalize the biogenesis of these substances.
In 1835, Wöhler wrote: “Die organische
Chemie kann einen jetzt ganz toll ma-
chen. Sie kommt mir wie ein Urwald der
Tropenländer vor, voll der merkwürdig-
sten Dinge, ein ungeheures Dickicht, ohne
Ausgang und Ende, in das man sich nicht
hinein wagen mag.”
[1]
In the following
decades, scientists started to map out this
thicket, first by advances in structure elu-
cidation, by chemical synthesis and cor-
relation, and then by advancement in ana-
lytical instrumentation.
[2]
In the context of
these synthetic endeavors, many synthetic
relationships between postulated or actual
biogenetic intermediates were uncovered,
that then led to the formulation of biosyn-
thetic pathways for their production in the
natural system.
[3]
Efforts by hundreds and
thousands of scientists led to the elucida-
tion of metabolic pathways culminating in
the landscape that is taught to undergradu-
ate students in science and medicine to-
day. However, one might ask the question
if there are still unmapped territories in
Wöhler’s primordial jungle and if there are
new biosynthetic routes to be discovered.
In this highlight, we would like to present
unusual and rarely investigated mechanis-
tic hypotheses related to the biogenesis of
natural products. The feasibility of these
pathways has been validated by chemi-
cal synthesis. While it is interesting to
speculate about mechanistic ramifications
in biochemistry, this work presents a sug-
gestion to further investigate the presence
of such routes in nature. In addition, this
account is limited to examples from our
own research group, which are obviously
selective and biased, and are by no means
comprehensive.
2. Biogenetic Proposals
Investigated by Chemical Synthesis
Periconianone A (1) was recently
isolated from the endophytic fungus
Periconia sp. F-31, which is found in the
medicinal plant Annona muricata.
[4]
The
eremophilane-type sesquiterpenoid fea-
tures an architecturally complex, rigid, and
highly oxidized molecular structure with a
unique 6/6/6 tricarbocyclic framework and
five contiguous stereocenters. The final
ring closure to complete the cage-like skel-
eton is biogenetically proposed to be the
result of a late-stage aldol addition in 2.
[4]
The bicycle 2 itself is proposed to be de-
rived from eremophilane (3) through sev-
eral oxidative transformations.
[4]
Inspired
by the proposed biosynthetic pathway, we
envisaged to mimic this late-stage aldol
reaction in order to establish the stereo-
genic centers at C4 and C12 and to form
the strained framework from the highly
oxidized precursor 4. The main synthetic
challenges of this transformation are the
construction of a motif with two contigu-
ous all-carbon quaternary stereocenters
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In a collective synthesis of icetex-
ane natural products, we investigated the
B-ring expansion of abietane diterpenoids
to the 6/7/6 tricyclic framework and have
delivered evidence that the 6/6/6 abietane
skeleton could be a biosynthetic precursor
of the icetexanes.
[13]
Mechanistically, the
transformation of 15 (via carnosic acid ob-
tained from rosemary) to 16 and 17 is ex-
plained by formation of a primary carboca-
tion at C20 in the 6/6/6 skeleton 15, which
immediately undergoes ring-expansion via
a [1,2]-shift of the C9–C10 bond to form
the more stable tertiary carbocation 18
(Scheme 4). Results published earlier have
already described experimental evidence
for the formation of alkenes 16 by deprot-
onation of 18.
[14]
However, trapping of 18
by water to install the oxygen function at
the C10 position to form the icetexanes has
not been reported previous to this work and
had been debated in the literature for de-
cades.
[15]
Attack of water from the β face
to form the desired icetexanes had been
considered to be sterically disfavored.
[15c]
However, the exclusively observed β se-
lectivity in our approach supports a non-
enzymatic mechanism for this transforma-
tion. Following our biomimetic route, we
were able to access the natural products
salvicanol (19), komaroviquinone (20), cy-
clocoulterone (21), and komarovispirone
(22), starting from carnosic acid, which
was obtained as dimethoxycarnosatemeth-
yl ester from rosemary upon derivatization
(Scheme 4). Additionally, we applied the
Othermembers of the taiwaniaquinoids
family which have aroused our synthetic
interest are taiwaniaquinone F (12), as
well as its rearranged methylene-bridged
catechol taiwaniaquinol A (13). The total
synthesis of taiwaniaquinone F has been
achieved via a protecting-group-free route
starting from sugiol methyl ether (14, pre-
pared form commercially available abi-
etic acid (8)) in nine steps.
[10]
The B-ring
contraction to the 6/5/6 skeleton has been
accomplished in a Wolff rearrangement
by irradiating the α-diazoketone derived
from 14 with a medium pressure Hg lamp.
When taiwaniaquinone F (12) was exposed
to light during purification, formation of
taiwaniaquinol A (13) was observed, and
by exposure of a diluted solution of 12
to sunlight, we were able to perform this
transformation to 13 with 30% isolated
yield (Scheme 3). For several natural prod-
ucts, studies describe the involvement of
cytochrome P450 enzymes in the oxida-
tive cyclization to the benzo[1,3]dioxole
units.
[11]
However, in the context of our
biomimetic synthesis to taiwaniaquinol
A, we were able to mimic this transforma-
tion as a redox-neutral, light-mediated and
enzyme-free remote C–H activation pro-
cess. The occurrence and distribution of
taiwaniaquinone F and taiwaniaquinolA in
the plant Taiwania crytomerioides further
supports our biosynthetic hypothesis by a
light-mediated process, since the former
was isolated from the bark and the latter
from the leaves of the same plant.
[12]
(C4 and C5), high ring strain in the forma-
tion of the cage-like framework, as well as
the intermediacy of labile β-hydroxy ke-
tone 4, prone to elimination and retro-aldol
reactions.
In order to probe the biogenetic key
transformation, an efficient and enantio-
selective synthetic route starting from
commercially available (R)-carvone (5)
was developed and gave access to isomeri-
cally pure aldehyde 4 in 15 linear steps.
Distinctive features of this route are the
use of an isopropenyl group as a removable
directing group for stereoselective syn-
thesis, a Rh-mediated tandem O-H inser-
tion/[3,3]-sigmatropic rearrangement and
subsequent α-ketol rearrangement. Using
various basic and acidic conditions for the
key transformation only induced a retro-al-
dol reaction by cleavage of propanal from
4 to form the undesired diosphenol. After
extensive screening, organic phosphonic
acids were shown to mediate the desired
substrate-controlled aldol cyclization in a
regio- and diastereoselective manner, and
without significant side product formation,
even in the presence of the free tertiary al-
cohol at C7. Treatment of aldehyde 4 with
diphenyl phosphate in toluene at 65 °C
gave the tricycle in 71% yield and full dia-
stereoselectivity and final oxidation gave
access to periconianoneA (1, Scheme 1).
[5]
The taiwaniaquinoids are a family of
diterpenoids possessing an unusual 6/5/6
carbocyclic system containing a benzylic
quaternary stereogenic center. They often
feature a CHO group at different positions
(C
20
taiwaniaquinoids) or are devoid of a
C atom (C
19
taiwaniaquinoids) represent-
ing norditerpenoids.
[6]
Our biogenetic hy-
pothesis towards C
19
taiwaniaquinoids is
based on a B-ring contraction of the abi-
etane-type 6/6/6 tricyclic systems, to form
the corresponding taiwaniaquinoid 6/5/6
system and is supported by reports on the
biosynthesis of gibberellins.
[7]
In the total
synthesis of taiwaniaquinoneH (6),
[8]
treat-
ment of oxidized ferruginol (7, synthesized
from abietic acid (8)) with LHMDS has
been shown to trigger a rearrangement to
the ketone 9. The mechanism of this reac-
tion is proposed to be internal nucleophilic
attack of the deprotonated hydroxy group,
resulting in the 3-oxetanone intermediate
10. The biosynthetic intermediacy of 10
is further supported by the occurrence of
more than 20 steroid derivatives contain-
ing 3-oxetanone moieties in their B-ring.
[9]
Oxetanone 10 is then proposed to undergo
the key benzilic acid rearrangement to
form lactone intermediate 11, followed
by decarboxylation to the norditerpenoid
framework 9. Ketone 9 was converted to
taiwaniaquinone H in a six-step protocol
and the total synthesis has been achieved
without the use of a protecting group
(Scheme 2).
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lecular [1,3]-dipolar cycloaddition, which
triggered synthetic efforts by three groups,
including ours, towards its preparation.
[22]
All synthetic efforts involve such a cycload-
Flueggea virosa
[21]
and displays an inter-
esting cage-like structure as a member of
the Securinega alkaloids. Virosaine A was
suggested to be the product of an intramo-
light-promoted remote C-H activation in
the reaction of 20 to 21 and 22, and pro-
vided additional experimental evidence for
the feasibility of this transformation.
Complex dimeric diterpenoids have
been rarely isolated and the structural
complexity obtained by dimerization is
remarkable. For the icetexane class, gran-
dione has already been synthesized,
[16,17]
whereas obtusinones D and E were iso-
lated from Premna obtusifolia and postu-
lated to be the result of a [4+2] cycload-
dition reaction.
[18]
Evaluating this hypoth-
esis, we prepared the quinone 23, which
we demonstrated to be not identical to
the structure of przewalskin E.
[13]
Heating
neat quinone 23 at 100 °C for six hours
led to the formation of both obtusinone D
and E in 69% yield and in a 1.7:1 ratio.
Separation of the natural products by chro-
matography proved to be difficult, and the
trick was to use additional toluene to break
down stacking for subsequent separation.
The NMR spectra matched to the reported
data, but X-ray crystal structure analysis
established that configurations at C13 and
C14 were opposite.
[13]
Based on this evi-
dence, we proposed a structural revision of
both compounds to the structures shown in
Scheme 5.
Securinega alkaloids constitute an in-
teresting class of alkaloids that display
highly functionalized complex structures
reaching out to oligomeric congeners.
[19]
Their biogenesis has been suggested to
start from lysine and tyrosine, with 26 as
an intermediate. Hypotheses for the bio-
genesis of Securinega alkaloids featuring
a bicyclo [3.2.1] skeleton (e.g. allosecuri-
nine (27)) or a bicyclo [2.2.2] skeleton (e.g.
secu’amamine E (28)) emanating from this
central precursor have been formulated.
In contrast, a linear hypothesis in which
secu’amamine E is a biosynthetic inter-
mediate en route to the [3.2.1] congener
can be formulated. By using chemical syn-
thesis, we prepared both secu’amamine E
and the nor-congener, bubbialidine (29).
[20]
Interestingly, both compounds readily con-
vert to the rearranged products allosecuri-
nine (30) or (–)-allonorsecurinine (31), re-
spectively. In the case of bubbialine (32),
which displays a synperiplanar arrange-
ment of the aminoalcohol unit, such a rear-
rangement is not directly possible, and the
mesylate intermediate 33 was observed.
Forcing conditions converted this inter-
mediate to the product allonorsecurinine
(34, Scheme 6). Based on this evidence, it
is suggested that an aziridinium interme-
diate 35 might be involved in this trans-
formation, and its ease of formation via
suitable arrangement of the non-bonding
orbital of the N atom into the σ* orbital of
the C-OMs bond.
The complex alkaloid virosaine A (36)
was isolated from the twigs and leaves of
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ties to the natural product. The chemical
feasibility of this nitrone olefin cycloaddi-
tion suggests the possibility of this process
to occur in nature, although this still needs
to be further investigated. A recent compu-
tational study provided further mechanistic
insight.
[23]
3. Conclusion
In this account, we presented an over-
view of chemical exploratory work into
yet underexplored mechanistic possibili-
ties of biosynthetic transformations. Many
of these examples suggest that the biosyn-
thetic realm in terms of reactions is not
fully mapped out, and that reactions such
as benzilic acid rearrangements or [3+2]
cycloaddition reactions might be involved
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Scheme 7. Total synthesis of virosaine A via a proposed [3+2]-nitrone olefin cycloaddition.
